Expert Review of Anti-Infective Therapy

Papers
(The H4-Index of Expert Review of Anti-Infective Therapy is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies169
Azithromycin in the treatment of COVID-19: a review159
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up150
Resolution of coronavirus disease 2019 (COVID-19)110
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications101
The use of IV vitamin C for patients with COVID-19: a case series98
Sepsis-associated encephalopathy and septic encephalitis: an update94
Antimicrobial resistance in low- and middle-income countries: current status and future directions81
Exercise and well-being during COVID 19 – time to boost your immunity76
Quorum quenching enzymes and their effects on virulence, biofilm, and microbiomes: a review of recent advances73
Functionalized carbon-based nanomaterials and quantum dots with antibacterial activity: a review68
Can nanotechnology help in the fight against COVID-19?65
COVID-19: fighting the invisible enemy with microRNAs62
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination62
Calycosin: a Review of its Pharmacological Effects and Application Prospects54
Moxidectin: an oral treatment for human onchocerciasis51
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae50
CAR-T cell therapy and infection: a review47
Point prevalence surveys of antimicrobial use: a systematic review and the implications47
Alternative approaches to treat bacterial infections: targeting quorum-sensing46
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials45
Old and re-purposed drugs for the treatment of COVID-1944
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis44
Update on the epidemiology of carbapenemases in Latin America and the Caribbean43
Current and emerging strategies to combat antimalarial resistance41
Improper disposal of unused antibiotics: an often overlooked driver of antimicrobial resistance40
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management39
Multidrug-resistantCandida auris: an epidemiological review38
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications35
Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends34
MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale34
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-233
Tackling Antimicrobial Resistance by promoting Antimicrobial stewardship in Medical and Allied Health Professional Curricula32
0.037922143936157